The Cost-Effectiveness of Vancomycin Powder in Lumbar Laminectomy

Yehuda E Kerbel1, Gregory J Kirchner1, Anisha Reddy Sunkerneni1

  • 112312Drexel University, Philadelphia, PA, USA.

Global Spine Journal
|September 3, 2020
PubMed
Abstract

Insights

Prophylactic vancomycin powder is cost-effective for lumbar laminectomy, potentially preventing infections and reducing healthcare costs. This analysis shows economic justification even at higher drug prices.

Area of Science:

  • Spinal Surgery
  • Infectious Disease Prevention
  • Health Economics

Background:

  • Surgical site infections (SSIs) following lumbar laminectomy pose significant risks and increase healthcare expenditures.
  • Prophylactic antibiotic strategies are crucial for mitigating SSIs in spinal procedures.
  • The cost-effectiveness of specific prophylactic agents, like vancomycin powder, requires rigorous economic evaluation.

Purpose of the Study:

  • To evaluate the cost-effectiveness of using vancomycin powder for infection prevention in patients undergoing lumbar laminectomy.
  • To determine the threshold for infection rate reduction (absolute risk reduction) at which vancomycin powder becomes economically justifiable.
  • To compare the cost-effectiveness of vancomycin powder in lumbar laminectomy versus lumbar laminectomy with fusion.

Main Methods:

  • A break-even cost analysis was conducted.
  • Institutional purchasing records provided the cost of vancomycin powder.
  • Infection rates and revision costs were sourced from existing literature for lumbar laminectomy and lumbar laminectomy with fusion.

Main Results:

  • Vancomycin powder at $3.06/gram is cost-effective for lumbar laminectomy if infection rates decrease by an absolute risk reduction (ARR) of 0.015%.
  • For lumbar laminectomy with fusion, vancomycin powder is cost-effective with an ARR of 0.0034% at the same institutional cost.
  • Even at a literature-reported high cost of $44.00/gram, vancomycin powder remained cost-effective with ARRs of 0.21% and 0.048% for laminectomy and laminectomy with fusion, respectively.

Conclusions:

  • Prophylactic vancomycin powder demonstrates high cost-effectiveness for lumbar laminectomy procedures.
  • Economically, vancomycin powder is justified at the institution if it prevents at least one infection in every 6700 lumbar laminectomy surgeries.
  • The findings support the routine use of vancomycin powder to reduce infection rates and associated costs in spinal surgery.

Related Concept Videos

Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.1K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
613
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
110